Randomized trial · people
Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In this head-to-head trial, daily liraglutide led to less weight loss than weekly semaglutide over 68 weeks, and more people stopped taking it, while gut side effects were similar for both.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 338
- Published
- 2022
- Journal
- JAMA
What they tested
The team compared how much weight people lost, and what side effects they had, on daily liraglutide versus weekly semaglutide.
How the study was done
A randomized phase 3b trial at 19 US sites in 338 adults with overweight or obesity and no diabetes, who received daily liraglutide 3.0 mg, weekly semaglutide 2.4 mg or placebo (a dummy shot) for 68 weeks, along with diet and physical activity advice. Participants knew which of the two drugs they were on, but neither drug group knew whether they had the drug or its matching placebo.

Model. Individual results vary.
What they found
At 68 weeks, body weight fell by 6.4% on average in the liraglutide arm, compared with 15.8% in the semaglutide arm and 1.9% with pooled placebo, a difference between the two drugs of -9.4 percentage points. A loss of 10% or more was reached by 25.6% of people on liraglutide versus 70.9% on semaglutide, and a loss of 20% or more by 6.0% versus 38.5%. More people stopped liraglutide than semaglutide (27.6% vs 13.5%). Stomach and gut side effects were about as common in both arms: 82.7% with liraglutide and 84.1% with semaglutide.
What it doesn’t show
The two drugs were compared open-label, so participants knew which one they were taking. The trial included only adults without diabetes, mostly women (78.4%), at US sites, and it lasted 68 weeks.
The paper
Rubino et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022.
The compounds
More studies on Liraglutide
- Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 yearRandomized trial · people · 2021
- Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADERRandomized trial · people · 2016
- Liraglutide: 8.4 kg lost vs 2.8 kg on placebo at 56 weeksRandomized trial · people · 2015
- Every study on Liraglutide
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.